Search results for "Highlights"
Bentonite hemostatic powder noninferior to standard care for GI bleeding
In a single-blind randomized controlled trial, bleeding was controlled within 30 days in 90.1% of adults with acute nonvariceal bleeding on upper GI endoscopy assigned to receive TC-325 versus 81.4% of those assigned to standard treatment.
https://gastroenterology.acponline.org/archives/2021/12/17/3.htm
17 Dec 2021
Metabolic syndrome may be linked to pancreatic cancer risk
A nationwide cohort study in Korea found that risk for pancreatic cancer decreased in patients whose metabolic syndrome improved versus persisted over time.
https://gastroenterology.acponline.org/archives/2021/10/22/2.htm
22 Oct 2021
AGA releases new guidance on coagulation disorders in patients with cirrhosis
A clinical practice guideline from the American Gastroenterological Association (AGA) suggested against extensive preprocedural testing in patients with stable cirrhosis who are undergoing routine GI procedures, among other recommendations.
https://gastroenterology.acponline.org/archives/2021/11/19/3.htm
19 Nov 2021
Person-to-person transmission now more common source of hepatitis A in U.S. than food
An analysis of hepatitis outbreaks in 2016 to 2020, comprising 37,553 cases, found that 56% of patients reported drug use, 14% reported homelessness, 12% reported recent incarceration, and 3% reported recent international travel.
https://gastroenterology.acponline.org/archives/2022/10/28/1.htm
28 Oct 2022
Patient-facing web platform helped identify those with higher colorectal cancer risk
A program that asked patients to enter their family health history identified more high-risk patients but didn't change rates of colorectal cancer screening or genetic counseling, a trial of U.S. veterans found.
https://gastroenterology.acponline.org/archives/2022/11/18/1.htm
18 Nov 2022
Self-administered questionnaire may help evaluate patients' cirrhosis knowledge
The questionnaire, which covered medication use and accessibility, medication obstacles, lactulose use, diuretic use, beta-blocker use, and dietary sodium use, was validated in a study of 582 outpatients and 131 inpatients.
https://gastroenterology.acponline.org/archives/2022/09/23/1.htm
23 Sep 2022
Severe COVID-19 associated with more IBS, less constipation
A prospective multicenter study found that patients hospitalized for COVID-19 had significantly higher rates of irritable bowel syndrome (IBS) and fewer problems with constipation at 12 months than controls.
https://gastroenterology.acponline.org/archives/2022/12/23/1.htm
23 Dec 2022
GI bleeding risks with warfarin and DOACs compared
Warfarin was associated with a similar risk of lower GI bleeding as direct oral anticoagulants (DOACs) but more than twice the rate of upper GI bleeding, which led study authors to suggest that DOACs may be preferable to warfarin in patients at high risk of upper GI bleeds.
https://gastroenterology.acponline.org/archives/2022/08/26/1.htm
26 Aug 2022
NAFLD progression associated with increased mortality risk
Patients with stage F4 nonalcoholic fatty liver disease (NAFLD) have significantly increased risk for liver-related complications, type 2 diabetes, and all-cause mortality compared to those with earlier stages, an observational prospective study found.
https://gastroenterology.acponline.org/archives/2021/10/22/3.htm
22 Oct 2021
Urinary biomarker may help predict cirrhosis outcomes, study finds
Levels of urine liver fatty acid-binding protein could be used together with Model for End-stage Liver Disease scoring to improve predictions of liver failure or death, according to an analysis of patients hospitalized for decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2021/09/24/3.htm
24 Sep 2021